Order out of chaos

The cover shows an artistic representation of various cancer cells. The large-scale gains, losses and rearrangements of DNA seen in chromosomal instability are a typical feature of cancer — but there is no comprehensive framework to decode the causes of this genomic variability and their possible links to disease. In this week’s issue, Florian Markowetz, Geoff Macintyre and their colleagues present such a framework with a compendium of 17 signatures of chromosomal instability that can be used to predict how tumours might respond to drugs and that help to identify future therapeutic targets. The team created the compendium by examining 7,880 tumours representing 33 types of cancer. In a separate paper, Nischalan Pillay and colleagues examined 9,873 cancers to generate